These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35560238)

  • 1. Cost-effectiveness of pathogen reduction technology for plasma and platelets in Québec: A focus on potential emerging pathogens.
    Grégoire Y; Delage G; Custer B; Rochette S; Renaud C; Lewin A; Germain M
    Transfusion; 2022 Jun; 62(6):1208-1217. PubMed ID: 35560238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing Pathogen Reduction Technology in Poland: A Cost-Utility Analysis.
    Agapova M; Lachert E; Brojer E; Letowska M; Grabarczyk P; Custer B
    Transfus Med Hemother; 2015 May; 42(3):158-65. PubMed ID: 26195929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of screening the U.S. blood supply for West Nile virus.
    Custer B; Busch MP; Marfin AA; Petersen LR
    Ann Intern Med; 2005 Oct; 143(7):486-92. PubMed ID: 16204161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system.
    Cicchetti A; Coretti S; Sacco F; Rebulla P; Fiore A; Rumi F; Di Bidino R; Urbina LI; Refolo P; Sacchini D; Spagnolo AG; Midolo E; Marano G; Farina B; Pati I; Veropalumbo E; Pupella S; Liumbruno GM
    Blood Transfus; 2018 Nov; 16(6):483-489. PubMed ID: 30201081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
    Hockenhull J; Elremeli M; Cherry MG; Mahon J; Lai M; Darroch J; Oyee J; Boland A; Dickson R; Dundar Y; Boyle R
    Health Technol Assess; 2012; 16(12):III-IV, 1-110. PubMed ID: 22409877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Analyses of Pathogen-Reduction Technologies in Blood Transfusion: A Systematic Literature Review.
    LaFontaine PR; Yuan J; Prioli KM; Shah P; Herman JH; Pizzi LT
    Appl Health Econ Health Policy; 2021 Jul; 19(4):487-499. PubMed ID: 33555572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model.
    Tappenden P; Carroll C; Hamilton J; Kaltenthaler E; Wong R; Wadsley J; Moss L; Balasubramanian S
    Health Technol Assess; 2019 Feb; 23(8):1-144. PubMed ID: 30821231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States.
    Bell CE; Botteman MF; Gao X; Weissfeld JL; Postma MJ; Pashos CL; Triulzi D; Staginnus U
    Clin Ther; 2003 Sep; 25(9):2464-86. PubMed ID: 14604745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic Artery Embolization for Benign Prostatic Hyperplasia: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(6):1-139. PubMed ID: 34188733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.
    Fonarow GC; Keech AC; Pedersen TR; Giugliano RP; Sever PS; Lindgren P; van Hout B; Villa G; Qian Y; Somaratne R; Sabatine MS
    JAMA Cardiol; 2017 Oct; 2(10):1069-1078. PubMed ID: 28832867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
    Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
    Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
    Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
    J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(12):1-134. PubMed ID: 33240453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.